David Taber to Dose-Response Relationship, Drug
This is a "connection" page, showing publications David Taber has written about Dose-Response Relationship, Drug.
Connection Strength
0.385
-
Dosing Requirements of Extended-Release Tacrolimus (Astagraf XL) in African American Kidney Transplant Recipients Converted from Immediate-Release Tacrolimus (AAAKTRS). Ther Drug Monit. 2020 06; 42(3):415-420.
Score: 0.129
-
African-American race modifies the influence of tacrolimus concentrations on acute rejection and toxicity in kidney transplant recipients. Pharmacotherapy. 2015 Jun; 35(6):569-77.
Score: 0.091
-
Racial comparisons of everolimus pharmacokinetics and pharmacodynamics in adult kidney transplant recipients. Ther Drug Monit. 2013 Dec; 35(6):753-9.
Score: 0.082
-
Tacrolimus dosing requirements and concentrations in adult living donor liver transplant recipients. Liver Transpl. 2002 Mar; 8(3):219-23.
Score: 0.036
-
Effect of Angiotensin II Inhibitors on Gastrointestinal Bleeding in Patients With Left?Ventricular Assist Devices. J Am Coll Cardiol. 2019 04 16; 73(14):1769-1778.
Score: 0.030
-
A critical analysis of racial difference with mycophenolate mofetil (MMF) dosing, clinical outcomes and adverse effects in pediatric kidney transplant patients. Clin Transplant. 2011 Jul-Aug; 25(4):534-40.
Score: 0.016